# Plasma Exchange With Albumin in AMN Patients

> **NCT04303416** · PHASE2,PHASE3 · COMPLETED · sponsor: **Pujol, Aurora, M.D.** · enrollment: 5 (actual)

## Conditions studied

- Adrenomyeloneuropathy
- Adrenoleukodystrophy

## Interventions

- **DRUG:** Albumin solution

## Key facts

- **NCT ID:** NCT04303416
- **Lead sponsor:** Pujol, Aurora, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-09
- **Primary completion:** 2021-02-24
- **Final completion:** 2021-09-13
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2022-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303416, "Plasma Exchange With Albumin in AMN Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04303416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*